A Rising Titan: TTN Review and Mutation Update

C Chauveau, J Rowell, A Ferreiro - Human mutation, 2014 - Wiley Online Library
The 364 exon TTN gene encodes titin (TTN), the largest known protein, which plays key
structural, developmental, mechanical, and regulatory roles in cardiac and skeletal muscles …

Increasing role of titin mutations in neuromuscular disorders

M Savarese, J Sarparanta, A Vihola… - Journal of …, 2016 - content.iospress.com
The TTN gene with 363 coding exons encodes titin, a giant muscle protein spanning from
the Z-disk to the M-band within the sarcomere. Mutations in the TTN gene have been …

Expanding the boundaries of RNA sequencing as a diagnostic tool for rare Mendelian disease

HD Gonorazky, S Naumenko, AK Ramani… - The American Journal of …, 2019 - cell.com
Gene-panel and whole-exome analyses are now standard methodologies for mutation
detection in Mendelian disease. However, the diagnostic yield achieved is at best 50 …

[HTML][HTML] Validation of a next-generation sequencing assay for clinical molecular oncology

CE Cottrell, H Al-Kateb, AJ Bredemeyer… - The Journal of molecular …, 2014 - Elsevier
Currently, oncology testing includes molecular studies and cytogenetic analysis to detect
genetic aberrations of clinical significance. Next-generation sequencing (NGS) allows rapid …

Interpreting genetic variants in titin in patients with muscle disorders

M Savarese, L Maggi, A Vihola, PH Jonson… - JAMA …, 2018 - jamanetwork.com
Importance Mutations in the titin gene (TTN) cause a wide spectrum of genetic diseases. The
interpretation of the numerous rare variants identified inTTNis a difficult challenge given its …

Targeted next-generation sequencing assay for detection of mutations in primary myopathies

A Evilä, M Arumilli, B Udd, P Hackman - Neuromuscular Disorders, 2016 - Elsevier
Mutations in more than 100 different genes are known to cause hereditary primary
myopathies. In patients with less distinct phenotypes several genes may have to be …

Progress and prospects of gene therapy clinical trials for the muscular dystrophies

NE Bengtsson, JT Seto, JK Hall… - Human molecular …, 2016 - academic.oup.com
Clinical trials represent a critical avenue for new treatment development, where early
phases (I, I/II) are designed to test safety and effectiveness of new therapeutics or diagnostic …

Identifying children with poor cochlear implantation outcomes using massively parallel sequencing

CC Wu, YH Lin, TC Liu, KN Lin, WS Yang, CJ Hsu… - Medicine, 2015 - journals.lww.com
Cochlear implantation is currently the treatment of choice for children with severe to
profound hearing impairment. However, the outcomes with cochlear implants (CIs) vary …

VaRank: a simple and powerful tool for ranking genetic variants

V Geoffroy, C Pizot, C Redin, A Piton, N Vasli… - PeerJ, 2015 - peerj.com
Background. Most genetic disorders are caused by single nucleotide variations (SNVs) or
small insertion/deletions (indels). High throughput sequencing has broadened the catalogue …

Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain

L Gonzalez-Quereda, MJ Rodriguez, J Diaz-Manera… - Genes, 2020 - mdpi.com
The term neuromuscular disorder (NMD) includes many genetic and acquired diseases and
differential diagnosis can be challenging. Next-generation sequencing (NGS) is especially …